Sort
10,766 grants matching “checkpoint inhibitor”
Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis Complex
$523,592Elizabeth P Henske · Brigham And Women'S Hospital · R01 · FY2025 · DK
Caspases in Inflammatory Cell Death Networks
$522,895Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · GM
Caspases in Inflammatory Cell Death Networks
$522,895Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · GM
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$522,708Anton Wellstein · Georgetown University · R01 · FY2022 · CA
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
$522,459Yong Wan · Northwestern University At Chicago · R01 · FY2021 · CA
Intravesical Immunotherapy of Spontaneous Canine Invasive Urothelial Carcinoma
$522,345David Zaharoff · North Carolina State University Raleigh · U01 · FY2023 · CA
Tissue Resident memory T cell responses to cancer
$522,276Mary J Turk · Dartmouth College · R01 · FY2022 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity
$522,237David C Linehan · University Of Rochester · R01 · FY2021 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$522,215Judith A. Varner · University Of California, San Diego · R01 · FY2025 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$522,215Judith A. Varner · University Of California, San Diego · R01 · FY2024 · CA
Checkpoint Function of PTPalpha in Pathological Fibrogenesis in the Lung
$522,172Gregory Paul Downey · National Jewish Health · R01 · FY2016 · HL
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
$522,110J. Silvio Gutkind · University Of California, San Diego · R01 · FY2025 · CA
Rare Central Nervous System Cancers Initiative
$522,109Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Translational Immunology
$522,109Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of novel human Fab probes for PET imaging of macrophages
$522,031Bernadette Marquez-Nostra · University Of Alabama At Birmingham · R01 · FY2023 · EB
Investigating a new vulnerability in oral squamous cell carcinoma
$521,948Christine M Eischen · Thomas Jefferson University · R01 · FY2025 · DE
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.
$521,831Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.
$521,831Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Enhancing the Potency and Durability of Immunotherapies
$521,774Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA
FEEDBACK CONTROL OF THE CELL CYCLE
$521,746Andrew W Murray · Harvard University · R37 · FY2006 · GM
Stromal Regulation of Basal Cell Carcinoma Formation
$521,703Anthony E Oro · Stanford University · R01 · FY2025 · AR
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$521,546Justin M Balko · Vanderbilt University Medical Center · R01 · FY2020 · CA
FEEDBACK CONTROL OF THE CELL CYCLE
$521,535Andrew W Murray · Harvard University · R37 · FY2007 · GM
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$521,454Zihai Li · Ohio State University · R01 · FY2024 · CA
Project 1: Evaluating stem-like T cells and improving efficacy of checkpoint inhibitors in NSCLC
$521,029Rafi Ahmed · Emory University · P50 · FY2019 · CA